Skip to main content
SpringerLink
Log in

Interventionelle Mitralklappentherapie

Interventional mitral valve therapy

  • CME Zertifizierte Fortbildung
  • Published:
Der Kardiologe Aims and scope

Zusammenfassung

Die Mitralklappenvalvuloplastie hat sich als erstes perkutanes Verfahren auf dem Gebiet der interventionellen Mitralklappentherapie etabliert. Das Spektrum an perkutanen Interventionsmethoden und -möglichkeiten hat sich zwischenzeitlich erheblich erweitert, sodass mittlerweile sowohl Mitralinsuffizienzen unterschiedlicher Ätiologien als auch paravalvuläre Mitralklappenlecks mit Kathetertechniken erfolgreich behandelt werden können. Im Folgenden sollen Kriterien besprochen werden, anhand derer Patienten adäquat für die jeweiligen Prozeduren selektiert werden können. Des Weiteren werden die prozeduralen Schritte für die jeweiligen Verfahren skizziert und assoziierte Komplikationen beschrieben.

Abstract

Mitral balloon valvuloplasty for rheumatic mitral valve stenosis was the first percutaneous intervention to gain wide acceptance in the field of mitral interventions; however, over time the range of interventional treatment options has rapidly evolved and new techniques have recently been developed to successfully treat degenerative and functional mitral regurgitation as well as paravalvular mitral leaks by the use of catheter techniques. This article provides criteria for adequate patient selection for percutaneous treatment of each of these entities. In addition, the procedural steps along with associated complications for each of the entities are discussed

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8
Abb. 9
Abb. 10

Literatur

  1. Wood P (1954) An appreciation of mitral stenosis, I: clinical features. Br Med J 4870:1051

    Article  Google Scholar 

  2. Iung B, Baron G, Butchart EG et al (2003) A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24:1231–1243

    Article  PubMed  Google Scholar 

  3. Seckeler MD, Hoke TR (2011) The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol 3:67–84

    Article  PubMed Central  PubMed  Google Scholar 

  4. Inoue K, Owaki T, Nakamura T et al (1984) Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 87:394–402

    CAS  PubMed  Google Scholar 

  5. Borger MA, Carrel TP, De Bonis M et al (2012) Guidelines on the mangagement of valvular heart disease (version 2012) The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 33:2451–2496

    Article  PubMed  Google Scholar 

  6. Nishimura RA, Otto CM, Bonow RO et al (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Am Coll Cardiol 63(22):2438–2488

    Article  PubMed  Google Scholar 

  7. Lancellotti P, Tribouilloy C, Hagendorff A et al (2013) Scientific Document Committee of the European Association of Cardiovascular Imaging. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 14(7):611–644

    Article  PubMed  Google Scholar 

  8. Wilkins GT, Weyman AE, Abascal VM et al (1988) Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 60:299–308

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Anwar AM, Attia WM, Nosir YF et al (2010) Validation of a new score for the assessment of mitral stenosis using real-time three-dimensional echocardiography. J Am Soc Echocardiogr 23(1):13–22

    Article  PubMed  Google Scholar 

  10. Iung BL, Garbarz E, Michaud P et al (1999) Late results of percutaneous mitral commissurotomy in a series of 1024 patients: analysis of late clinical deterioration: frequency, anatomic findings and predictive factors. Circulation 99:3272–3278

    Article  CAS  PubMed  Google Scholar 

  11. Sanati HR, Zahemehr A, Shakerian F et al (2012) Percutaneous mitral valvuloplasty using echocardiographic intercommissural diameter as reference for balloon sizing: a randomized controlled trial. Clin Cardiol 35(12):749–754

    Article  PubMed  Google Scholar 

  12. Nkomo VT, Gardin JM, Skelton TN et al (2006) Burden of valvular heart diseases: a population-based study. Lancet 368:1005–1011

    Article  PubMed  Google Scholar 

  13. Enriquez-Sarano M, Loulmet DF, Burkhoff D (2008) The conundrum of functional mitral regurgitation in chronic heart failure. J Am Coll Cardiol 51:487–489

    Article  PubMed  Google Scholar 

  14. Alfieri O, Maisano F, DeBonis M et al (2001) The edge-to-edge technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 122:674–681

    Article  CAS  PubMed  Google Scholar 

  15. Feldman T, Kar S, Rinaldi M et al (2009) Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 54:686–694

    Article  PubMed  Google Scholar 

  16. Feldman T, Foster E, Glower DD et al (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364:1395–1406

    Article  CAS  PubMed  Google Scholar 

  17. Mauri L, Foster E, Glower DD et al (2013) 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol 62:317–328

    Article  PubMed  Google Scholar 

  18. Wan B, Rahnavardi M, Tian DH et al (2013) A meta-analysis of MitraClip system versus surgery for treatment of severe mitral regurgitation. Ann Cardiothorac Surg 2:683–692

    PubMed Central  PubMed  Google Scholar 

  19. Reichenspurner H, Schillinger W, Baldus S et al (2013) Clinical outcomes through 12 months in patients with degenerative mitral regurgitation treated with the MitraClip device in the ACCESS-Europe Phase I trial. Eur J Cardiothorac Surg 44(4):e280–e288

    Article  PubMed  Google Scholar 

  20. Franzen O, Heyden J van der, Baldus S et al (2011) MitraClip therapy in patients with end-stage systolic heart failure. Eur J Heart Failure 13:569–576

    Article  Google Scholar 

  21. Franzen O, Baldus S, Rudolph V et al (2010) Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 31:1373–1381

    Article  PubMed  Google Scholar 

  22. Auricchio A et al (2012) Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by mitraclip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 58:2183–2189 [Eur J Heart Fail 14(8):803–869]

  23. McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC Committee for Practice Guidelines ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14(8):803–869

    Article  CAS  PubMed  Google Scholar 

  24. Pate GE, Zubaidi A, Chandavimol M et al (2006) Percutaneous closure of prosthetic paravalvular leaks: case series and review. Catheter Cardiovasc Interv 68:528–533

    Article  PubMed  Google Scholar 

  25. Echevarria JR, Bernal JM, Rabasa JM et al (1991) Reoperation for bioprosthetic valve dysfunction. A decade of clinical experience. Eur J Cardiothorac Surg 5:523–526 (Discussion 527)

    Article  CAS  PubMed  Google Scholar 

  26. Expósito V, Garcia-Camarero T, Bernal JM et al (2009) Repeat mitral valve replacement: 30-years‘ experience. Rev Esp Cardiol 62(8):929–932

    Article  PubMed  Google Scholar 

  27. Hourihan M, Perry SB, Mandell VS et al (1992) Transcatheter umbrella closure of valvular and paravalvular leaks. J Am Coll Cardiol 20(6):1371–1377

    Article  CAS  PubMed  Google Scholar 

  28. Vitarelli A, Conde Y, Cimino E et al (2004) Assessment of severity of mechanical prosthetic mitral regurgitation by transesophageal echocardiography. Heart 90:539–544

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Dvir D, Webb J, Brecker S et al (2012) Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the Global Valve-in-Valve Registry. Circulation 126:2335–2344

    Article  PubMed  Google Scholar 

  30. Makkar RR, Jilaihawi H, Chakravarty T et al (2013) Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a Study of Multiple Valve Implants in the US PARTNER Trial. J Am Coll Cardiol 62(5):418–430

    Article  PubMed  Google Scholar 

  31. Cheung AW, Gurvitch R, Ye J et al (2011) Transcatheter transapical mitral valve-in valve implantations for a failed bioprosthesis: a case series. J Thorac Cardiovacs Surg 141:711–715

    Article  Google Scholar 

  32. Seiffert M, Conradi L, Baldus S et al (2012) Transcatheter mitral valve-in-valve implantation in patients with degenerated bioprostheses. JACC Cardiovasc Interv 5:341–349

    Article  PubMed  Google Scholar 

  33. Descoutures F, Himbert D, Maisano F et al (2013) Transcatheter valve-in-ring implantation after failure of surgical mitral repair. Eur J Cardiothorac Surg 44:e8–e15

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. N.C. Wunderlich: Vortragshonorare und Reisekostenerstattungen der Firmen Abbott, St. Jude Medical und Philips. H. Ince: Proctor für Abbott. S. Kische und G. D’Ancona geben an, dass kein Interessenskonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Kardiovaskuläres Zentrum Darmstadt, Dieburgerstrasse 31c, 64287, Darmstadt, Deutschland

    N.C. Wunderlich

  2. Klinik für Innere Medizin – Kardiologie und konservative Intensivmedizin, Vivantes Klinikum im Friedrichshain und Am Urban, Landsberger Allee 49, 10249, Berlin, Deutschland

    S. Kische, G. D’Ancona &  H. Ince

Authors
  1. N.C. Wunderlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Kische
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. D’Ancona
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Ince
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to N.C. Wunderlich or H. Ince.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wunderlich, N., Kische, S., D’Ancona, G. et al. Interventionelle Mitralklappentherapie. Kardiologe 8, 477–498 (2014). https://doi.org/10.1007/s12181-014-0606-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-014-0606-8

Schlüsselwörter

Keywords

Search

Navigation